Leadership Team

About

The current leadership team at Arrowhead Pharmaceuticals has a wealth of experience in the pharmaceutical industry. The CSO, or Chief Scientific Officer, has worked at Calando Pharmaceuticals and Insert Therapeutics in the past, and has a background in Biotechnology and Process Engineering from ETH Zürich. The Principal Scientist at Arrowhead Pharmaceuticals previously worked at Schering-Plough Research Institute and did a post-doctoral associate at MIT.

Team members

Christopher Anzalone

President & CEO

Dave Bormett

VP, Quality Assurance

Ken Myszkowski

CFO

Patrick C. O’Brien

COO & General Counsel

Randy Steiner

VP, Regulatory Affairs

Thomas Schluep

VP, Program Management

Tracie Oliver

Chief Commercial Officer

Other teams at Arrowhead Pharmaceuticals

View all

DG
MF
MP
+3

Board of Directors

6 members

+1

CEO and Executive Team

4 members

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.